Operating Expenses Summary of Avecho Biotechnology Limited

Avecho Biotechnology Limited's latest annual operating expenses in 2023 was 4.54 Million AUD , up 13.22% from previous year.
Avecho Biotechnology Limited's latest quarterly operating expenses in 2024 Q2 was 3.1 Million AUD , down 0.0% from previous quarter.
Avecho Biotechnology Limited reported a annual operating expenses of 3.85 Million AUD in annual operating expenses 2022, up 2.61% from previous year.
Avecho Biotechnology Limited reported a annual operating expenses of 3.75 Million AUD in annual operating expenses 2021, up 125.26% from previous year.
Avecho Biotechnology Limited reported a quarterly operating expenses of 2.73 Million AUD for 2023 Q2, down 0.0% from previous quarter.
Avecho Biotechnology Limited reported a quarterly operating expenses of 4.36 Million AUD for 2023 FY, up 13.22% from previous quarter.

Annual Operating Expenses Chart of Avecho Biotechnology Limited (2023 - 1993)

Historical Annual Operating Expenses of Avecho Biotechnology Limited (2023 - 1993)

Year	Operating Expenses	Operating Expenses Growth
2023	4.54 Million AUD	13.22%
2022	3.85 Million AUD	2.61%
2021	3.75 Million AUD	125.26%
2020	1.66 Million AUD	-7.23%
2019	1.79 Million AUD	-63.08%
2018	4.87 Million AUD	-49.84%
2017	9.71 Million AUD	-48.01%
2016	18.67 Million AUD	-13.52%
2015	21.59 Million AUD	51.12%
2014	14.29 Million AUD	-23.93%
2013	18.78 Million AUD	13.73%
2012	16.51 Million AUD	7.0%
2011	15.43 Million AUD	57.58%
2010	9.79 Million AUD	-0.47%
2009	9.84 Million AUD	-20.58%
2008	12.39 Million AUD	-7.44%
2007	13.38 Million AUD	34.82%
2006	9.93 Million AUD	24.98%
2005	7.94 Million AUD	351.8%
2004	1.75 Million AUD	68.12%
2003	1.04 Million AUD	0.87%
2002	1.03 Million AUD	-3.89%
2001	1.07 Million AUD	145.95%
2000	-2.34 Million AUD	-333.13%
1999	1 Million AUD	113.04%
1998	-7.72 Million AUD	83.25%
1997	-46.1 Million AUD	-585.22%
1996	-6.72 Million AUD	-117.54%
1995	38.36 Million AUD	3629.35%
1994	-1.08 Million AUD	-146.69%
1993	2.32 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	3.1 Million AUD	0.0%
2023 Q2	2.73 Million AUD	0.0%
2023 FY	4.36 Million AUD	13.22%
2023 Q4	1.63 Million AUD	0.0%
2022 Q4	2.11 Million AUD	0.0%
2022 Q2	1.51 Million AUD	0.0%
2022 FY	3.85 Million AUD	2.61%
2021 Q2	1.37 Million AUD	0.0%
2021 Q4	2.38 Million AUD	0.0%
2021 FY	3.75 Million AUD	125.26%
2020 Q4	870.34 Thousand AUD	0.0%
2020 FY	1.66 Million AUD	-7.23%
2020 Q2	798.33 Thousand AUD	0.0%
2019 Q2	1.05 Million AUD	0.0%
2019 Q4	740.6 Thousand AUD	0.0%
2019 FY	1.79 Million AUD	-63.08%
2018 FY	4.87 Million AUD	-49.84%
2018 Q2	2.31 Million AUD	0.0%
2018 Q4	2.55 Million AUD	0.0%
2017 FY	9.71 Million AUD	-48.01%
2017 Q2	4.96 Million AUD	0.0%
2016 FY	18.67 Million AUD	-13.52%
2016 Q4	12.1 Million AUD	0.0%
2016 Q2	6.56 Million AUD	0.0%
2015 FY	21.59 Million AUD	51.12%
2015 Q4	12.43 Million AUD	0.0%
2015 Q2	9.16 Million AUD	0.0%
2014 Q4	6.91 Million AUD	1279.1%
2014 Q1	501.25 Thousand AUD	0.0%
2014 Q2	2.54 Million AUD	408.13%
2014 FY	14.29 Million AUD	-23.93%
2014 Q3	501.25 Thousand AUD	-80.32%
2013 Q3	1.02 Million AUD	-84.09%
2013 Q4	501.25 Thousand AUD	-51.15%
2013 FY	18.78 Million AUD	13.73%
2013 Q1	1.02 Million AUD	0.0%
2013 Q2	6.44 Million AUD	528.46%
2012 Q2	305.25 Thousand AUD	0.0%
2012 Q1	305.25 Thousand AUD	0.0%
2012 Q4	1.02 Million AUD	236.12%
2012 FY	16.51 Million AUD	7.0%
2012 Q3	305.25 Thousand AUD	0.0%
2011 Q4	305.25 Thousand AUD	-9.69%
2011 Q3	338 Thousand AUD	0.0%
2011 Q2	338 Thousand AUD	0.0%
2011 FY	15.43 Million AUD	57.58%
2011 Q1	338 Thousand AUD	0.0%
2010 FY	9.79 Million AUD	-0.47%
2010 Q3	397.75 Thousand AUD	0.0%
2010 Q4	338 Thousand AUD	-15.02%
2010 Q1	397.75 Thousand AUD	0.0%
2010 Q2	397.75 Thousand AUD	0.0%
2009 Q2	293.5 Thousand AUD	0.0%
2009 Q4	397.75 Thousand AUD	35.52%
2009 Q3	293.5 Thousand AUD	0.0%
2009 FY	9.84 Million AUD	-20.58%
2009 Q1	293.5 Thousand AUD	0.0%
2008 Q1	283.5 Thousand AUD	0.0%
2008 Q2	283.5 Thousand AUD	0.0%
2008 Q3	283.5 Thousand AUD	0.0%
2008 Q4	293.5 Thousand AUD	3.53%
2008 FY	12.39 Million AUD	-7.44%
2007 Q2	531.25 Thousand AUD	0.0%
2007 FY	13.38 Million AUD	34.82%
2007 Q1	531.25 Thousand AUD	0.0%
2007 Q3	531.25 Thousand AUD	0.0%
2007 Q4	283.5 Thousand AUD	-46.64%
2006 FY	9.93 Million AUD	24.98%
2006 Q4	531.25 Thousand AUD	37.36%
2006 Q3	386.75 Thousand AUD	0.0%
2006 Q2	386.75 Thousand AUD	0.0%
2006 Q1	386.75 Thousand AUD	0.0%
2005 Q2	442.75 Thousand AUD	0.0%
2005 Q4	386.75 Thousand AUD	-12.65%
2005 Q3	442.75 Thousand AUD	0.0%
2005 FY	7.94 Million AUD	351.8%
2005 Q1	442.75 Thousand AUD	0.0%
2004 Q4	442.75 Thousand AUD	114.11%
2004 FY	1.75 Million AUD	68.12%
2004 Q2	206.78 Thousand AUD	0.0%
2004 Q3	206.78 Thousand AUD	0.0%
2004 Q1	206.78 Thousand AUD	0.0%
2003 Q2	142.23 Thousand AUD	0.0%
2003 Q4	206.78 Thousand AUD	45.39%
2003 Q3	142.23 Thousand AUD	0.0%
2003 Q1	142.23 Thousand AUD	0.0%
2003 FY	1.04 Million AUD	0.87%
2002 FY	1.03 Million AUD	-3.89%
2002 Q4	142.23 Thousand AUD	-21.03%
2002 Q3	180.12 Thousand AUD	0.0%
2002 Q2	180.12 Thousand AUD	0.0%
2002 Q1	180.12 Thousand AUD	0.0%
2001 Q1	154.08 Thousand AUD	0.0%
2001 FY	1.07 Million AUD	145.95%
2001 Q2	154.08 Thousand AUD	0.0%
2001 Q4	180.12 Thousand AUD	16.9%
2001 Q3	154.08 Thousand AUD	0.0%
2000 Q3	-587 Thousand AUD	0.0%
2000 Q4	154.08 Thousand AUD	126.25%
2000 FY	-2.34 Million AUD	-333.13%
2000 Q2	-587 Thousand AUD	0.0%
2000 Q1	-587 Thousand AUD	0.0%
1999 Q3	251.78 Thousand AUD	0.0%
1999 FY	1 Million AUD	113.04%
1999 Q1	251.78 Thousand AUD	0.0%
1999 Q2	251.78 Thousand AUD	0.0%
1999 Q4	-587 Thousand AUD	-333.14%
1998 FY	-7.72 Million AUD	83.25%
1998 Q4	251.78 Thousand AUD	113.04%
1998 Q3	-1.93 Million AUD	0.0%
1998 Q2	-1.93 Million AUD	0.0%
1998 Q1	-1.93 Million AUD	0.0%
1997 Q2	-11.52 Million AUD	0.0%
1997 Q1	-11.52 Million AUD	0.0%
1997 Q3	-11.52 Million AUD	0.0%
1997 FY	-46.1 Million AUD	-585.22%
1997 Q4	-1.93 Million AUD	83.25%
1996 Q2	-1.68 Million AUD	0.0%
1996 Q4	-11.52 Million AUD	-585.22%
1996 Q1	-1.68 Million AUD	0.0%
1996 Q3	-1.68 Million AUD	0.0%
1996 FY	-6.72 Million AUD	-117.54%
1995 Q4	-1.68 Million AUD	-117.54%
1995 FY	38.36 Million AUD	3629.35%
1995 Q1	9.59 Million AUD	0.0%
1995 Q2	9.59 Million AUD	0.0%
1995 Q3	9.59 Million AUD	0.0%
1994 Q3	-271.75 Thousand AUD	0.0%
1994 FY	-1.08 Million AUD	-146.69%
1994 Q1	-271.75 Thousand AUD	0.0%
1994 Q4	9.59 Million AUD	3629.35%
1994 Q2	-271.75 Thousand AUD	0.0%
1993 FY	2.32 Million AUD	0.0%
1993 Q2	582 Thousand AUD	0.0%
1993 Q4	-271.75 Thousand AUD	-146.69%
1993 Q1	582 Thousand AUD	0.0%
1993 Q3	582 Thousand AUD	0.0%
1992 Q4	582 Thousand AUD	0.0%

Peer Operating Expenses Comparison of Avecho Biotechnology Limited

Name	Operating Expenses	Operating Expenses Difference
AdAlta Limited	6.76 Million AUD	32.855%
Biome Australia Limited	7.91 Million AUD	42.545%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-1419.04%
Biotron Limited	5.11 Million AUD	11.061%
Acrux Limited	8.55 Million AUD	46.837%
Alterity Therapeutics Limited	23.4 Million AUD	80.581%
Botanix Pharmaceuticals Limited	601.82 Thousand AUD	-655.275%
BTC Health Limited	-1.03 Million AUD	537.509%
Chimeric Therapeutics Limited	19.76 Million AUD	77.006%
CSL Limited	7.56 Billion AUD	99.94%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	91.928%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	85.477%
Immutep Limited	42.87 Million AUD	89.399%
Memphasys Limited	3.67 Million AUD	-23.57%
Neuren Pharmaceuticals Limited	32.69 Million AUD	86.098%
Noxopharm Limited	7 Million AUD	35.068%
Prescient Therapeutics Limited	10.89 Million AUD	58.294%
Race Oncology Limited	14.77 Million AUD	69.226%
Starpharma Holdings Limited	22.81 Million AUD	80.078%
Tissue Repair Ltd	6.66 Million AUD	31.821%
EZZ Life Science Holdings Limited	39.57 Million AUD	88.514%
Anatara Lifesciences Ltd	710.21 Thousand AUD	-540.001%
Bio-Gene Technology Limited	2.76 Million AUD	-64.628%
Zelira Therapeutics Limited	5.94 Million AUD	23.588%
Patrys Limited	4.93 Million AUD	7.863%
Orthocell Limited	15.36 Million AUD	70.426%
Imugene Limited	135.09 Million AUD	96.635%
PYC Therapeutics Limited	60.91 Million AUD	92.538%
Proteomics International Laboratories Limited	892.14 Thousand AUD	-409.492%
Cynata Therapeutics Limited	11.12 Million AUD	59.137%
Arovella Therapeutics Limited	10.78 Million AUD	57.856%
Nanollose Limited	12.5 Thousand AUD	-36260.243%
Invex Therapeutics Ltd	3.34 Million AUD	-35.85%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	-131.292%
Amplia Therapeutics Limited	8.43 Million AUD	46.117%
Island Pharmaceuticals Limited	4.12 Million AUD	-10.182%
Nyrada Inc.	4.55 Million AUD	0.215%
Telix Pharmaceuticals Limited	269.26 Million AUD	98.312%
Dimerix Limited	25.64 Million AUD	82.275%
PharmAust Limited	6.65 Million AUD	31.72%
Hexima Limited	1 Million AUD	-350.597%
AnteoTech Limited	12.18 Million AUD	62.703%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	93.018%
Recce Pharmaceuticals Ltd	21.68 Million AUD	79.038%
Actinogen Medical Limited	22.77 Million AUD	80.038%
Immuron Limited	9.13 Million AUD	50.258%
Argenica Therapeutics Limited	8.26 Million AUD	45.032%

Global Stocks Search

Avecho Biotechnology Limited (AVE.AX)

Operating Expenses Summary of Avecho Biotechnology Limited

Annual Operating Expenses Chart of Avecho Biotechnology Limited (2023 - 1993)

Historical Annual Operating Expenses of Avecho Biotechnology Limited (2023 - 1993)

Peer Operating Expenses Comparison of Avecho Biotechnology Limited